New drug cocktail aims to stall advanced lung cancer
NCT ID NCT05798663
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This study tests whether adding an experimental immunotherapy drug (tiragolumab) to standard immunotherapy (atezolizumab) plus chemoradiation helps people with stage III lung cancer live longer without the disease getting worse. About 178 participants will receive either the two-drug combo or atezolizumab alone, alongside standard treatment. The goal is to see which approach better delays cancer progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hematology Oncology Associates of Central New York, P.C.
East Syracuse, New York, 13057, United States
-
Kaiser Permanente Oakland Medical Center
Oakland, California, 94611, United States
-
Kaiser Permanente Roseville Medical Center
Roseville, California, 95661, United States
-
Kaiser Permanente San Francisco Medical Center
San Francisco, California, 94115, United States
-
Kaiser Permanente Santa Clara Medical Center
Santa Clara, California, 95051, United States
-
Kaiser Permanente Vallejo Medical Center
Vallejo, California, 94589, United States
-
Missouri Baptist Medical Center
St Louis, Missouri, 63131, United States
-
New Hampshire Oncology - Hematology, PA
Manchester, New Hampshire, 03103, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
-
University of California San Diego Moores Cancer Center
La Jolla, California, 92037, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Washington University Siteman Cancer Center
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.